Invex Therapeutics Receives green light for IIH trial in NZ
Invex Therapeutics (IXC) will commence its IIH EVOLVE Phase III clinical trial after receiving...
Invex Therapeutics Receives UK approval to start phase III Presendin trial
Invex Therapeutics (IXC) gets the tick of approval to start its phase III...
